Stephen Pauker

From Rutgers Medical Informatics History Project

(Difference between revisions)
Jump to: navigation, search
Line 12: Line 12:
OtherInfo=|
OtherInfo=|
CV=|
CV=|
-
SelectedPublications=|
+
SelectedPublications=Helfand M, Tunis S, Whitlock EP, Pauker SG, Basu A, Chilingerian J, Harrell FE
 +
Jr, Meltzer DO, Montori VM, Shepard DS, Kent DM; Methods Work Group of the
 +
National CTSA Strategic Goal Committee on Comparative Effectiveness Research. A
 +
CTSA agenda to advance methods for comparative effectiveness research. Clin
 +
Transl Sci. 2011 Jun;4(3):188-98. doi: 10.1111/j.1752-8062.2011.00282.x.
 +
 
 +
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working
 +
Group. Recommendations from the EGAPP Working Group: routine testing for Factor
 +
V
 +
Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of
 +
idiopathic venous thromboembolism and their adult family members. Genet Med. 201
 +
1
 +
Jan;13(1):67-76.
 +
 
 +
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working
 +
Group. Recommendations from the EGAPP Working Group: genomic profiling to assess
 +
 +
cardiovascular risk to improve cardiovascular health. Genet Med. 2010
 +
Dec;12(12):839-43.
 +
 
 +
Pauker SG, Salem DN. Measuring duty hours made simple. Am J Med. 2010
 +
Nov;123(11):e17; author reply e19.
 +
 
 +
|
Books=|
Books=|
AdditionalMedia=|
AdditionalMedia=|
Sources=
Sources=
}}
}}

Revision as of 03:43, 3 February 2012

Pauker1.jpg

Name: Stephan G. Pauker, MD

Elected ACMI Fellow: 1984

Birthdate:

Degrees:

Current Position:

Current email:

Professional Affiliations:

Professional Activities:

Honors and Awards:

Other Works:

Other Information:

Curriculum Vitae:


Selected Publications:

Helfand M, Tunis S, Whitlock EP, Pauker SG, Basu A, Chilingerian J, Harrell FE
Jr, Meltzer DO, Montori VM, Shepard DS, Kent DM; Methods Work Group of the
National CTSA Strategic Goal Committee on Comparative Effectiveness Research. A
CTSA agenda to advance methods for comparative effectiveness research. Clin
Transl Sci. 2011 Jun;4(3):188-98. doi: 10.1111/j.1752-8062.2011.00282.x.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working 
Group. Recommendations from the EGAPP Working Group: routine testing for Factor 
V
Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of
idiopathic venous thromboembolism and their adult family members. Genet Med. 201
1
Jan;13(1):67-76.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working 
Group. Recommendations from the EGAPP Working Group: genomic profiling to assess
 
cardiovascular risk to improve cardiovascular health. Genet Med. 2010
Dec;12(12):839-43.

Pauker SG, Salem DN. Measuring duty hours made simple. Am J Med. 2010
Nov;123(11):e17; author reply e19.

Books


Additional Media:


Sources:

Personal tools